Furthermore, anti-inflammatory adipokines, such as adiponectin, were found to be reduced in T2D patients with lower levels of apelin, but these results were inconsistent in T1D patients [21,69]. The gene discussed is APLN; the disease is type 2 diabetes mellitus.